Glimsay MV 1 Tablet SR
Marketer
Meraki Health
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimsay MV 1 Tablet SR
Diabetic patients using the anti-diabetic medication, Glimsay MV 1 SR tablet, should understand its combined formulation for managing type 2 diabetes in adults. This medication regulates blood glucose, and optimal results require consistent daily dosing at the same time, ideally with food. Dosage is personalized and subject to adjustment based on blood sugar monitoring. Discontinuing Glimsay MV 1 SR without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms one part of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by a physician. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Patients should be prepared to counteract hypoglycemia with readily available glucose, such as sweets or fruit juice. Alcohol consumption increases this risk and should be minimized. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is also possible. Glimsay MV 1 SR is contraindicated for patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart conditions should inform their physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is essential, alongside periodic blood tests to assess blood cell counts and liver function as determined by the prescribing doctor.
Primary Ingredients of Glimsay MV 1 Tablet SR
No text was provided. Please provide the text you wish me to rephrase.
Uses of Glimsay MV 1 Tablet SR
Managing Type 2 Diabetes
Major Benefits of Glimsay MV 1 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Administer Glimsay MV 1 Tablet SR on an empty stomach.
Common Side effects of Glimsay MV 1 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimsay MV 1 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimsay MV 1 Tablet SR on an empty stomach.
How Glimsay MV 1 Tablet SR works:
Glimsay MV 1 Tablet, sustained-release formulation, contains a triple-drug combination for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimsay MV 1 Tablet SR is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Glimsay MV 1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimsay MV 1 Tablet may pose a risk to breastfeeding infants. Available human data indicates potential transfer to breast milk with possible infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glimsay MV 1 Tablet SR is likely inadvisable for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, its application is discouraged in those experiencing severe kidney dysfunction.
LiverCAUTION
Exercise caution when prescribing Glimsay MV 1 Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate Glimsay MV 1 Tablet SR therapy at a reduced dosage; however, its use is contraindicated in those with severe liver disease.
What if you forget to take Glimsay MV 1 Tablet SR :
Should you forget to take a Glimsay MV 1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimsay MV 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |




